Maybelle Kou

Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies

Cyrus R. Kumana, Au W., L. Mart n et al. · European Journal of Clinical Pharmacology · 2002 · 90 citations

Oral Arsenic-trioxide, Metalloid Contamination, Hematology +4

Hospital antibiotic prescribing successfully modified by ‘immediate concurrent feedback’

Tai-Yin Ching, Maybelle Kou, Sau-chu Chiang et al. · British Journal of Clinical Pharmacology · 1996 · 30 citations

Medication Administration, Pharmacotherapy, Oral Prescribing +19

Inability of Physicians to Use Metered-Dose Inhalers

K. Tsang, Wah-kit Lam, Maybelle Kou et al. · Journal of Asthma · 1997 · 30 citations

Asthma, Pulmonary Care, Mdi Inhalation Performance +10

Diltiazem co‐treatment in renal transplant patients receiving microemulsion cyclosporin

Cyrus R. Kumana, Matthew K. L. Tong, I Lauder et al. · British Journal of Clinical Pharmacology · 2003 · 21 citations · Full text

Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant <i>Staphylococcus aureus</i> infections

Cyrus R. Kumana, Tai Yin Ching, Yvonne Kong et al. · British Journal of Clinical Pharmacology · 2001 · 19 citations · Full text